Eva Herweijer

2.1k total citations
20 papers, 582 citations indexed

About

Eva Herweijer is a scholar working on Epidemiology, Surgery and Sociology and Political Science. According to data from OpenAlex, Eva Herweijer has authored 20 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 7 papers in Surgery and 4 papers in Sociology and Political Science. Recurrent topics in Eva Herweijer's work include Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (11 papers) and Genital Health and Disease (5 papers). Eva Herweijer is often cited by papers focused on Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (11 papers) and Genital Health and Disease (5 papers). Eva Herweijer collaborates with scholars based in Sweden, United States and Iceland. Eva Herweijer's co-authors include Pär Sparén, Lisen Arnheim‐Dahlström, Alexander Ploner, Karin Sundström, Amy Levál, Julia F. Simard, Ingrid Uhnoo, Joakim Dillner, Eva Netterlid and Sandra Eloranta and has published in prestigious journals such as JAMA, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Eva Herweijer

20 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Herweijer Sweden 12 501 205 89 57 56 20 582
Joaquín Luna Colombia 4 686 1.4× 314 1.5× 56 0.6× 79 1.4× 74 1.3× 9 743
Maria Garefalakis Australia 4 404 0.8× 174 0.8× 78 0.9× 51 0.9× 47 0.8× 4 450
Ross Cameron United Kingdom 11 495 1.0× 184 0.9× 50 0.6× 51 0.9× 103 1.8× 18 572
Madelief Mollers Netherlands 15 384 0.8× 164 0.8× 55 0.6× 34 0.6× 21 0.4× 21 510
Helen Kelly United Kingdom 14 342 0.7× 140 0.7× 149 1.7× 67 1.2× 23 0.4× 22 461
Katherine Giacoletti United States 6 673 1.3× 315 1.5× 44 0.5× 45 0.8× 85 1.5× 8 739
Joel Palefsky United States 5 471 0.9× 252 1.2× 84 0.9× 99 1.7× 16 0.3× 8 524
Maria Luiza Baggio United States 16 797 1.6× 552 2.7× 49 0.6× 147 2.6× 44 0.8× 33 933
Brahim Qadadri United States 13 628 1.3× 333 1.6× 154 1.7× 85 1.5× 31 0.6× 22 697
Bethany A Weaver United States 9 604 1.2× 372 1.8× 36 0.4× 67 1.2× 53 0.9× 9 689

Countries citing papers authored by Eva Herweijer

Since Specialization
Citations

This map shows the geographic impact of Eva Herweijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Herweijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Herweijer more than expected).

Fields of papers citing papers by Eva Herweijer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Herweijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Herweijer. The network helps show where Eva Herweijer may publish in the future.

Co-authorship network of co-authors of Eva Herweijer

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Herweijer. A scholar is included among the top collaborators of Eva Herweijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Herweijer. Eva Herweijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herweijer, Eva, et al.. (2025). Population-Level Impact of Human Papillomavirus Vaccination on the Incidence of Genital Warts in Sweden. The Journal of Infectious Diseases. 232(1). e54–e63. 4 indexed citations
2.
Blum, Maxim, Jeroen Geurtsen, Eva Herweijer, et al.. (2025). Epidemiology of invasive Escherichia coli disease in adults in England, 2013–2017. Epidemiology and Infection. 153. e4–e4. 1 indexed citations
3.
Herweijer, Eva, Kejia Hu, Jiangrong Wang, et al.. (2024). Incidence of oncogenic HPV infection in women with and without mental illness: A population-based cohort study in Sweden. PLoS Medicine. 21(3). e1004372–e1004372. 5 indexed citations
4.
5.
Herweijer, Eva, Jiangrong Wang, Kejia Hu, et al.. (2023). Overall and Cervical Cancer Survival in Patients With and Without Mental Disorders. JAMA Network Open. 6(9). e2336213–e2336213. 10 indexed citations
6.
Wang, Jiangrong, Eva Herweijer, Sara Nordqvist Kleppe, et al.. (2023). High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012–2019. Preventive Medicine Reports. 35. 102342–102342. 5 indexed citations
7.
Hu, Kejia, Jiangrong Wang, Pär Sparén, et al.. (2023). Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study. The Lancet Public Health. 8(4). e266–e275. 17 indexed citations
8.
Sundström, Karin, Eva Herweijer, & Jiangrong Wang. (2020). Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccination. Preventive Medicine. 144. 106382–106382. 4 indexed citations
9.
Dehlendorff, Christian, Pär Sparén, Birgitte Baldur‐Felskov, et al.. (2018). Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions. Vaccine. 36(43). 6373–6378. 31 indexed citations
10.
Herweijer, Eva, Alexander Ploner, & Pär Sparén. (2018). Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden. Vaccine. 36(15). 1917–1920. 22 indexed citations
11.
Lamb, Favelle, Eva Herweijer, Alexander Ploner, et al.. (2017). Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study. BMJ Open. 7(6). e015021–e015021. 13 indexed citations
12.
Lindbäck, Stefan, Magnus Gisslén, Leo Flamholc, et al.. (2017). HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014. PLoS ONE. 12(2). e0171227–e0171227. 16 indexed citations
13.
Lu, Donghao, Eva Herweijer, Karin Sundström, et al.. (2016). Sexually transmitted infections after bereavement – a population-based cohort study. BMC Infectious Diseases. 16(1). 419–419. 5 indexed citations
14.
Herweijer, Eva, Karin Sundström, Alexander Ploner, et al.. (2016). Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study. International Journal of Cancer. 138(12). 2867–2874. 101 indexed citations
15.
16.
Herweijer, Eva, Adina L. Feldman, Alexander Ploner, et al.. (2015). The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study. PLoS ONE. 10(7). e0134185–e0134185. 35 indexed citations
17.
Herweijer, Eva, Amy Levál, Alexander Ploner, et al.. (2014). Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma. JAMA. 311(6). 597–597. 73 indexed citations
18.
Levál, Amy, Eva Herweijer, Alexander Ploner, et al.. (2013). Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study. JNCI Journal of the National Cancer Institute. 105(7). 469–474. 113 indexed citations
19.
Elfström, K. Miriam, Eva Herweijer, Karin Sundström, & Lisen Arnheim‐Dahlström. (2013). Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination. Current Opinion in Oncology. 26(1). 120–129. 16 indexed citations
20.
Levál, Amy, Eva Herweijer, Lisen Arnheim‐Dahlström, et al.. (2012). Incidence of Genital Warts in Sweden Before and After Quadrivalent Human Papillomavirus Vaccine Availability. The Journal of Infectious Diseases. 206(6). 860–866. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquín Luna Breakdown of academic impact, for papers by Maria Garefalakis Breakdown of academic impact, for papers by Ross Cameron Breakdown of academic impact, for papers by Madelief Mollers Breakdown of academic impact, for papers by Helen Kelly Breakdown of academic impact, for papers by Katherine Giacoletti Breakdown of academic impact, for papers by Joel Palefsky Breakdown of academic impact, for papers by Maria Luiza Baggio Breakdown of academic impact, for papers by Brahim Qadadri Breakdown of academic impact, for papers by Bethany A Weaver
Rankless by CCL
2026